Therapeutic Drug Monitoring tests in Dubai & UAE

Compare available Therapeutic Drug Monitoring tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

550.00–4,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Therapeutic Drug Monitoring test prices

Showing 16–30 of 40 matching tests.

Therapeutic Drug Monitoring diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1024 Doxepin Test This diagnostic test evaluates the concentration of doxepin in the patient's serum.	Serum	3–5 Business Days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Doxepin Concentration"] Parameters [{"name": "Doxepin", "reference_range": null}] Preparation ["Collect sample 12 hours post-dose for steady-state trough levels", "No specific fasting required"] Indications ["Therapeutic drug monitoring of doxepin", "Assessment of adherence", "Investigation of suspected overdose or toxicity", "Evaluation of potential drug interactions affecting doxepin metabolism"] Measurement technique Confirm with laboratory Codes LOINC: 3396-2 ICD-10: Z51.81 Clinical summary This diagnostic test evaluates the concentration of doxepin in the patient's serum.
TEST-1078 Ethosuximide Test This test measures the concentration of ethosuximide in the serum to ensure therapeutic levels for seizure control while minimizing toxicity.	Serum	2–3 weeks (sample must be received by the 7th of the month)	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum trough concentration of ethosuximide"] Parameters [{"name": "Ethosuximide", "reference_range": "40–100 µg/mL"}] Preparation ["Collect sample immediately before the next oral dose", "Ensure patient has not missed a dose unless instructed by physician"] Indications ["Monitoring ethosuximide therapy", "Assessing adherence", "Investigating potential toxicity", "Adjusting dosage"] Measurement technique Confirm with laboratory Codes LOINC: 3474-6 ICD-10: Z51.81, G40.909 Clinical summary This test measures the concentration of ethosuximide in the serum to ensure therapeutic levels for seizure control while minimizing toxicity.
TEST-1079 Everolimus Blood Test (Therapeutic Drug Monitoring) This diagnostic test evaluates the concentration of everolimus in whole blood to optimize therapeutic dosing.	Whole Blood (EDTA)	24 to 48 hours	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Everolimus concentration"] Parameters [{"name": "Everolimus", "reference_range": null}] Preparation ["Schedule blood draw exactly 12 hours after last dose", "Provide exact time and amount of last dose"] Indications ["Post-transplant monitoring", "Dose adjustment guidance", "Monitoring for toxicity"] Measurement technique Confirm with laboratory Codes LOINC: 41690-2 ICD-10: Z94.0, T86.1, Z79.899 Clinical summary This diagnostic test evaluates the concentration of everolimus in whole blood to optimize therapeutic dosing.
TEST-1109 Felbamate Test This diagnostic test quantifies serum felbamate levels to guide therapeutic drug monitoring in epilepsy patients.	Serum	2–3 weeks (batch processing)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Felbamate Concentration"] Parameters [{"name": "Felbamate", "reference_range": "30–100 µg/mL"}] Preparation ["Collect serum 1 hour before the next dose", "Use a plain red-top tube without gel separator", "Send Out Consent Form (Form 35) is mandatory"] Indications ["Therapeutic drug monitoring for felbamate", "Assessing drug efficacy", "Monitoring for potential toxicity"] Measurement technique Confirm with laboratory Codes LOINC: 3586-2 ICD-10: Z79.899 Clinical summary This diagnostic test quantifies serum felbamate levels to guide therapeutic drug monitoring in epilepsy patients.
TEST-1245 Fluoxetine Blood Test This diagnostic test evaluates the concentration of fluoxetine and its active metabolite, norfluoxetine, in the patient's serum.	Serum	2–3 weeks	2,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Fluoxetine", "Serum Norfluoxetine"] Parameters [{"name": "Fluoxetine", "reference_range": "Therapeutic range 120–500 ng/mL (combined with norfluoxetine)"}, {"name": "Norfluoxetine", "reference_range": "Therapeutic range 120–500 ng/mL (combined with fluoxetine)"}] Preparation ["Collect blood >12 hours after the last oral dose (trough level).", "No fasting required.", "Avoid alcohol 24 hours before collection."] Indications ["Therapeutic drug monitoring for depression, OCD, and anxiety disorders", "Dose individualization", "Assessment of adherence", "Investigation of suspected toxicity or lack of efficacy"] Measurement technique Confirm with laboratory Codes LOINC: 3573-1 ICD-10: Z79.899 Clinical summary This diagnostic test evaluates the concentration of fluoxetine and its active metabolite, norfluoxetine, in the patient's serum.
TEST-1285 Gabapentin Test This diagnostic test evaluates the concentration of gabapentin in serum or plasma to guide therapeutic drug monitoring.	Serum or Plasma (peripheral whole blood)	5–7 business days from sample receipt	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum or plasma gabapentin concentration"] Parameters [{"name": "Gabapentin", "reference_range": "0.05 µg/mL limit of quantification"}] Preparation ["Blood must be drawn exactly 2 hours after your last gabapentin dose.", "Inform the phlebotomist of all medications and supplements you are taking."] Indications ["Therapeutic drug monitoring for epilepsy", "Therapeutic drug monitoring for neuropathic pain", "Assessing adherence to gabapentin therapy", "Investigating suspected toxicity or lack of efficacy"] Measurement technique Confirm with laboratory Codes LOINC: 3531-4 ICD-10: Z51.81 Clinical summary This diagnostic test evaluates the concentration of gabapentin in serum or plasma to guide therapeutic drug monitoring.
TEST-1369 HALOPERIDOL Therapeutic Drug Monitoring Test This diagnostic test evaluates the serum concentration of haloperidol to optimize therapeutic dosing and monitor for potential toxicity.	Serum	2–3 weeks	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Haloperidol Concentration", "Pharmacokinetic Assessment"] Parameters [{"name": "Haloperidol", "reference_range": null}] Preparation ["Collect sample 11–17 hours after the last dose.", "No specific fasting required."] Indications ["Monitoring therapeutic levels", "Assessing compliance", "Guiding dose adjustments", "Investigating suspected toxicity", "Evaluating drug interactions"] Measurement technique Confirm with laboratory Codes LOINC: 3543-8 ICD-10: Z51.81 Clinical summary This diagnostic test evaluates the serum concentration of haloperidol to optimize therapeutic dosing and monitor for potential toxicity.
TEST-2230 Immunosuppressant Drug Profile 2 Test This test measures the trough concentrations of four key immunosuppressant drugs (tacrolimus, cyclosporine, sirolimus, everolimus) in the blood.	Peripheral whole blood (EDTA)	Same day (sample by 5 PM)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Tacrolimus trough concentration", "Cyclosporine trough concentration", "Sirolimus trough concentration", "Everolimus trough concentration"] Parameters [{"name": "Tacrolimus", "reference_range": null}, {"name": "Cyclosporine", "reference_range": null}, {"name": "Sirolimus", "reference_range": null}, {"name": "Everolimus", "reference_range": null}] Preparation ["Draw blood within 30-60 minutes before the next scheduled dose.", "Fasting overnight is recommended if practical."] Indications ["Routine monitoring of transplant patients on immunosuppressants", "Dose adjustment of immunosuppressive therapy", "Investigation of suspected under- or over-immunosuppression"] Measurement technique Confirm with laboratory Codes LOINC: 72787-7 ICD-10: Z51.81, Z79.899 Clinical summary This test measures the trough concentrations of four key immunosuppressant drugs (tacrolimus, cyclosporine, sirolimus, everolimus) in the blood.
TEST-2257 Immunosuppressant Drug Profile 3 (ISP3) Test This test measures the concentration of specific immunosuppressant drugs in the blood.	Peripheral Whole Blood (EDTA)	Same-day report (sample by 5 pm)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Tacrolimus trough levels", "Cyclosporin trough levels", "Sirolimus trough levels", "Everolimus trough levels", "Mycophenolic acid trough levels"] Parameters [{"name": "Tacrolimus", "reference_range": null}, {"name": "Cyclosporin", "reference_range": null}, {"name": "Sirolimus", "reference_range": null}, {"name": "Everolimus", "reference_range": null}, {"name": "Mycophenolic Acid", "reference_range": null}] Preparation ["Collect blood sample immediately before the next scheduled dose.", "Record the last dose time and sampling time accurately on the collection tube.", "Do not take the morning dose until after the sample is drawn, unless otherwise instructed.", "Inform the phlebotomist about all current medications and recent dose changes."] Indications ["Post-transplant monitoring", "Management of patients on long-term immunosuppressive therapy", "Dose adjustments for immunosuppressants", "Monitoring for drug toxicity", "Monitoring for organ rejection"] Measurement technique Confirm with laboratory Codes LOINC: 101658-9 ICD-10: Z51.81 Clinical summary This test measures the concentration of specific immunosuppressant drugs in the blood.
TEST-2277 Infliximab (Anti‑TNF) Trough Level Test This diagnostic test evaluates the serum concentration of infliximab, a TNF-α blocker, at the trough level before the next infusion.	Serum (peripheral blood)	2–3 weeks from sample receipt (sample must arrive by the 7th of the month)	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum infliximab concentration", "Therapeutic drug monitoring"] Parameters [{"name": "Infliximab Trough Level", "reference_range": null}] Preparation ["No fasting required", "Inform phlebotomist of other biologic injections within the last 2 weeks"] Indications ["Monitoring infliximab therapy efficacy", "Guiding dose adjustments", "Investigating loss of response", "Assessing immunogenicity"] Measurement technique Confirm with laboratory Codes LOINC: 34107-0 ICD-10: Z51.81 Clinical summary This diagnostic test evaluates the serum concentration of infliximab, a TNF-α blocker, at the trough level before the next infusion.
TEST-2341 Lamotrigine (Lamictal) Therapeutic Drug Monitoring (TDM) Test This diagnostic test evaluates the concentration of lamotrigine in the patient's serum.	Serum	2–3 weeks	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Lamotrigine Concentration"] Parameters [{"name": "Lamotrigine", "reference_range": "2.5–15 μg/mL (Therapeutic Range)"}] Preparation ["Collect blood exactly 0.5–1 hour before the next dose.", "Use a red-top serum tube without SST gel."] Indications ["Optimizing lamotrigine dosage", "Monitoring for toxicity", "Assessing adherence", "Investigating lack of efficacy"] Measurement technique Confirm with laboratory Codes LOINC: 11444-9 ICD-10: Z51.81, F31.9, Z79.899 Clinical summary This diagnostic test evaluates the concentration of lamotrigine in the patient's serum.
TEST-2405 Levetiracetam Therapeutic Drug Monitoring (TDM) Test This test measures the concentration of levetiracetam in the serum to guide epilepsy treatment.	Serum	14–21 working days	2,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Levetiracetam Concentration"] Parameters [{"name": "Levetiracetam", "reference_range": "12–46 µg/mL (Therapeutic Window)"}] Preparation ["Collect blood just before the next scheduled dose (trough level).", "Use a plain Red Top tube (no additive).", "Do not use SST gel barrier tubes.", "No fasting is required."] Indications ["Optimizing levetiracetam dosage in epilepsy", "Monitoring for toxicity", "Assessing adherence", "Evaluating drug interactions", "Adjusting dose in renal impairment or pregnancy"] Measurement technique Confirm with laboratory Codes LOINC: 29631-0 ICD-10: Z79.81 Clinical summary This test measures the concentration of levetiracetam in the serum to guide epilepsy treatment.
TEST-2516 Mesoridazine Therapeutic Drug Monitoring Test This test measures the concentration of mesoridazine in the patient's serum to guide therapeutic dosing.	Serum	2–3 weeks (sample must arrive by 7th of month)	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mesoridazine concentration"] Parameters [{"name": "Mesoridazine", "reference_range": null}] Preparation ["Take medication as prescribed", "Complete and sign the Send Out Consent Form (Form 35)"] Indications ["Monitoring mesoridazine therapy", "Dose optimization", "Assessing adherence", "Preventing toxicity"] Measurement technique Confirm with laboratory Codes LOINC: 39479-6 ICD-10: Z51.81 Clinical summary This test measures the concentration of mesoridazine in the patient's serum to guide therapeutic dosing.
TEST-2569 Mitotane Therapeutic Drug Monitoring Test This diagnostic test evaluates the concentration of mitotane in a patient's serum.	Serum (peripheral whole blood)	2–3 weeks	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mitotane concentration in serum"] Parameters [{"name": "Mitotane", "reference_range": "14–20 mg/L (Therapeutic Range)"}] Preparation ["No special dietary restrictions apply.", "Take mitotane exactly as prescribed.", "Blood draw recommended 12 hours after the previous evening dose (trough level)."] Indications ["Monitoring patients on mitotane therapy for adrenocortical carcinoma", "Assessing therapeutic drug levels", "Adjusting dosage to optimize efficacy and minimize toxicity"] Measurement technique Confirm with laboratory Codes LOINC: 13980-1 ICD-10: Z51.81 Clinical summary This diagnostic test evaluates the concentration of mitotane in a patient's serum.
TEST-2678 Nortriptyline Test This diagnostic test evaluates the concentration of nortriptyline in the patient's serum.	Serum	2–3 weeks (batch‑optimised)	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Nortriptyline Concentration"] Parameters [{"name": "Nortriptyline", "reference_range": "50-150 ng/mL"}] Preparation ["Collect serum >12 hours after your last oral dose", "Use a plain red-top tube only", "Submit a signed consent form (Form 35)"] Indications ["Monitoring therapeutic drug levels", "Adjusting dosage", "Ruling out overdose", "Assessing compliance"] Measurement technique Confirm with laboratory Codes LOINC: 2074-0 ICD-10: Z79.89 Clinical summary This diagnostic test evaluates the concentration of nortriptyline in the patient's serum.

Category overview

Therapeutic Drug Monitoring: overview

Managing chronic conditions with specialized medications requires a delicate balance, and precise biological monitoring ensures your treatment remains safe and effective. Within our comprehensive Biochemistry services, Therapeutic Drug Monitoring measures the exact concentration of specific prescription medications in your bloodstream. By utilizing state-of-the-art diagnostic technology, this vital clinical testing provides your healthcare provider with the critical data needed to optimize dosing, prevent toxicity, and safely guide your personalized medical care. Widely respected for clinical excellence among diagnostic labs in the UAE, DNA Labs ensures strict patient confidentiality, unparalleled analytical accuracy, and highly efficient reporting for sensitive treatments. Take control of your medication management—schedule your therapeutic drug monitoring in UAE, book a seamless home sample collection, or consult our dedicated medical experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.